- Home
- WSR vs XERS Comparison
WSR vs XERS Comparison
Compare WSR & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSR
- XERS
- Stock Information
- Founded
- WSR 1998
- XERS 2005
- Country
- WSR United States
- XERS United States
- Employees
- WSR N/A
- XERS N/A
- Industry
- WSR Real Estate Investment Trusts
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- WSR Real Estate
- XERS Health Care
- Exchange
- WSR Nasdaq
- XERS Nasdaq
- Market Cap
- WSR 628.6M
- XERS 752.7M
- IPO Year
- WSR 2010
- XERS 2018
- Fundamental
- Price
- WSR $12.60
- XERS $5.02
- Analyst Decision
- WSR Strong Buy
- XERS Strong Buy
- Analyst Count
- WSR 2
- XERS 6
- Target Price
- WSR $15.00
- XERS $6.25
- AVG Volume (30 Days)
- WSR 252.6K
- XERS 2.0M
- Earning Date
- WSR 07-30-2025
- XERS 08-07-2025
- Dividend Yield
- WSR 4.29%
- XERS N/A
- EPS Growth
- WSR 26.93
- XERS N/A
- EPS
- WSR 0.61
- XERS N/A
- Revenue
- WSR $155,128,000.00
- XERS $222,551,000.00
- Revenue This Year
- WSR $2.00
- XERS $35.31
- Revenue Next Year
- WSR $5.14
- XERS $19.65
- P/E Ratio
- WSR $20.69
- XERS N/A
- Revenue Growth
- WSR 6.69
- XERS 29.88
- 52 Week Low
- WSR $11.78
- XERS $2.10
- 52 Week High
- WSR $15.36
- XERS $6.07
- Technical
- Relative Strength Index (RSI)
- WSR 52.21
- XERS 51.52
- Support Level
- WSR $12.40
- XERS $4.99
- Resistance Level
- WSR $12.64
- XERS $5.22
- Average True Range (ATR)
- WSR 0.21
- XERS 0.23
- MACD
- WSR -0.00
- XERS -0.02
- Stochastic Oscillator
- WSR 51.04
- XERS 43.37
About WSR Whitestone REIT
Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in metropolitan areas. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business friendly locations in and around Austin, Chicago, Dallas-Fort Worth, Houston, Phoenix, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).